Cancer immunization, which stimulates the immune system so it can defend itself against cancer cells and without major side effects for decades, researchers wondered to see the contents of this syringe. Now it seems a big step to be successful in this direction.
The hard part of the body's defense against cancer is that T-cells (killer cells) immune system, cancer cells do not always admit such or can not penetrate the infected tissue. Can then be spread metastasis, tumor growth.
High time for people with allergies begin in the fall with treatment
During a many years, researchers are trying to the immune system against cancer cells "make a sharp". Now they seem to have managed a breakthrough.
Cancer researchers because it tries to "make a sharp" immune cells against cancer. They want to manipulate the body's own defenses so that eating and killer cells directed specifically against malignant cells. In "Science" magazine Now researchers led by Ralf Bargou of the University of Würzburg great success in the treatment of Lymphkrebspatienten. Merreka Drug: bispecific antibody.
This is a specific antibody that has been a dream researcher Gert Riethmüller Munich had met ten years ago. At that time he has managed, Y-shaped molecules to produce genetically so that they can not recognize one, but two foreign molecules. Normally, antibodies bind with their short sleeves only one Y-type counterparts. Asymmetric molecules but now can bind two different partners. "So they form a bridge - and in our case, they easily cling blinatumomab antibodies with one arm Lymphkrebses of cells and other weapons killer cells," he said. "The cell killer is used very close to the cancer cells - and can speak directly inject their toxic contents into it." This is the end of cancer cells.
The hard part of the body's defense against cancer is that T-cells (killer cells) immune system, cancer cells do not always admit such or can not penetrate the infected tissue. Can then be spread metastasis, tumor growth.
High time for people with allergies begin in the fall with treatment
During a many years, researchers are trying to the immune system against cancer cells "make a sharp". Now they seem to have managed a breakthrough.
Cancer researchers because it tries to "make a sharp" immune cells against cancer. They want to manipulate the body's own defenses so that eating and killer cells directed specifically against malignant cells. In "Science" magazine Now researchers led by Ralf Bargou of the University of Würzburg great success in the treatment of Lymphkrebspatienten. Merreka Drug: bispecific antibody.
This is a specific antibody that has been a dream researcher Gert Riethmüller Munich had met ten years ago. At that time he has managed, Y-shaped molecules to produce genetically so that they can not recognize one, but two foreign molecules. Normally, antibodies bind with their short sleeves only one Y-type counterparts. Asymmetric molecules but now can bind two different partners. "So they form a bridge - and in our case, they easily cling blinatumomab antibodies with one arm Lymphkrebses of cells and other weapons killer cells," he said. "The cell killer is used very close to the cancer cells - and can speak directly inject their toxic contents into it." This is the end of cancer cells.
Comments
Post a Comment